The FDA-approved Spiration Valve System (SVS) is an innovative endobronchial technology that offers patients with severe emphysema a customized, minimally invasive treatment option for lung volume reduction with a favorable risk-benefit profile. In clinical trials, patients treated with the SVS experienced improved breathing, lung function and quality of life.
1 Criner GJ, et al. Am J Respir Crit Care Med. 2019.